ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sector of biopharmaceuticals, giving promising breakthroughs across a variety of healthcare and industrial apps. With its structural similarity to Normally derived human serum albumin, OsrHSA offers a safer, far more reputable option for therapeutic use, specially in